Schering Plans For Possible Clarinex Switch By Readying OTC Division
This article was originally published in The Tan Sheet
Executive Summary
Preparations for a possible Rx-to-OTC switch of Clarinex (desloratadine) will be directed by Schering Consumer Health Care Division Chairman Stanley Barshay